Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

PHASE4CompletedINTERVENTIONAL
Enrollment

1,508

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

January 31, 2009

Conditions
Acute Renal Failure
Interventions
PROCEDURE

"augmented CRRT regimen"

We randomly assigned critically ill patients with acute kidney injury to receive CRRT in the form of post-dilution continuous veno-venous hemodiafiltration (CVVHDF) at 25 ml/kg/hr (lower intensity) or 40 ml/kg/hr (higher intensity) of effluent flow.

Trial Locations (1)

3084

The Austin Hopsital, Heidelberg

Sponsors
All Listed Sponsors
collaborator

ANZICS Clinical Trials Group

NETWORK

lead

The George Institute

OTHER

NCT00221013 - Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF). | Biotech Hunter | Biotech Hunter